Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Clinical trial NCT05960578 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05960578
Sponsor: University of Washington
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Carcinoma Prostate Adenocarcinoma Stage IV Prostate Cancer AJCC v8

Start date: 2024-05-23
Primary completion: 2025-07-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.